Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life

Low‐grade gliomas frequently are associated with epilepsy. The purpose of this study is to determine the impact of epilepsy and antiepileptic drug (AED) treatment on cognitive functioning and health‐related quality of life (HRQOL) in these patients. One hundred fifty‐six patients without clinical or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of neurology 2003-10, Vol.54 (4), p.514-520
Hauptverfasser: Klein, Martin, Engelberts, Nadine H. J., van der Ploeg, Henk M., Kasteleijn-Nolst Trenité, Dorotheé G. A., Aaronson, Neil K., Taphoorn, Martin J. B., Baaijen, Hans, Vandertop, W. Peter, Muller, Martin, Postma, Tjeerd J., Heimans, Jan J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 520
container_issue 4
container_start_page 514
container_title Annals of neurology
container_volume 54
creator Klein, Martin
Engelberts, Nadine H. J.
van der Ploeg, Henk M.
Kasteleijn-Nolst Trenité, Dorotheé G. A.
Aaronson, Neil K.
Taphoorn, Martin J. B.
Baaijen, Hans
Vandertop, W. Peter
Muller, Martin
Postma, Tjeerd J.
Heimans, Jan J.
description Low‐grade gliomas frequently are associated with epilepsy. The purpose of this study is to determine the impact of epilepsy and antiepileptic drug (AED) treatment on cognitive functioning and health‐related quality of life (HRQOL) in these patients. One hundred fifty‐six patients without clinical or radiological signs of tumor recurrence for at least 1 year after histological diagnosis and with an epilepsy burden (based on seizure frequency and AED use) ranging from none to severe were compared with healthy controls. The association between epilepsy burden and cognition/HRQOL was also investigated. Eighty‐six percent of the patients had epilepsy and 50% of those using AEDs actually were seizure‐free. Compared with healthy controls, glioma patients had significant reductions in information processing speed, psychomotor function, attentional functioning, verbal and working memory, executive functioning, and HRQOL. The increase in epilepsy burden that was associated with significant reductions in all cognitive domains except for attentional and memory functioning could primarily be attributed to the use of AEDs, whereas the decline in HRQOL could be ascribed to the lack of complete seizure control. In conclusion, low‐grade glioma patients suffer from a number of neuropsychological and psychological problems that are aggravated by the severity of epilepsy and by the intensity of the treatment.
doi_str_mv 10.1002/ana.10712
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75731778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75731778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4552-794638614fb652317c1c21db9835e4a11a4634ed8f75733ad869a127512adda03</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhi0EotvCgT-AfKESh7QefybcVqEtlar20KIerVnHWQzOR-OEsv--WXahp5488jzvzOgh5AOwE2CMn2KLc2GAvyILUAKynMviNVkwoWWmQMgDcpjST8ZYoYG9JQcgFWdaqwW5PetD9H3a0NDS2D1m6wErT9cxdA2mL_Tuh6eh6dGNtGup69ZtGMNvT-updWOYv7Ct6MOEMYwb2tU0htq_I29qjMm_379H5Pv52V35Lbu6ubgsl1eZk0rxzBRSi1yDrFdacQHGgeNQrYpcKC8RAOe-9FVeG2WEwCrXBQI3CjhWFTJxRI53c_uhe5h8Gm0TkvMxYuu7KdltDIzJZ_DzDnRDl9Lga9sPocFhY4HZrUE7G7R_Dc7sx_3QadX46pncK5uBT3sAk8NYD9i6kJ45BabI5fa60x33OAvevLzRLq-X_1Znu0RIo__zP4HDL6uNMMreX19Y-bU8L2_vS1uIJywslI4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75731778</pqid></control><display><type>article</type><title>Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Klein, Martin ; Engelberts, Nadine H. J. ; van der Ploeg, Henk M. ; Kasteleijn-Nolst Trenité, Dorotheé G. A. ; Aaronson, Neil K. ; Taphoorn, Martin J. B. ; Baaijen, Hans ; Vandertop, W. Peter ; Muller, Martin ; Postma, Tjeerd J. ; Heimans, Jan J.</creator><creatorcontrib>Klein, Martin ; Engelberts, Nadine H. J. ; van der Ploeg, Henk M. ; Kasteleijn-Nolst Trenité, Dorotheé G. A. ; Aaronson, Neil K. ; Taphoorn, Martin J. B. ; Baaijen, Hans ; Vandertop, W. Peter ; Muller, Martin ; Postma, Tjeerd J. ; Heimans, Jan J.</creatorcontrib><description>Low‐grade gliomas frequently are associated with epilepsy. The purpose of this study is to determine the impact of epilepsy and antiepileptic drug (AED) treatment on cognitive functioning and health‐related quality of life (HRQOL) in these patients. One hundred fifty‐six patients without clinical or radiological signs of tumor recurrence for at least 1 year after histological diagnosis and with an epilepsy burden (based on seizure frequency and AED use) ranging from none to severe were compared with healthy controls. The association between epilepsy burden and cognition/HRQOL was also investigated. Eighty‐six percent of the patients had epilepsy and 50% of those using AEDs actually were seizure‐free. Compared with healthy controls, glioma patients had significant reductions in information processing speed, psychomotor function, attentional functioning, verbal and working memory, executive functioning, and HRQOL. The increase in epilepsy burden that was associated with significant reductions in all cognitive domains except for attentional and memory functioning could primarily be attributed to the use of AEDs, whereas the decline in HRQOL could be ascribed to the lack of complete seizure control. In conclusion, low‐grade glioma patients suffer from a number of neuropsychological and psychological problems that are aggravated by the severity of epilepsy and by the intensity of the treatment.</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.10712</identifier><identifier>PMID: 14520665</identifier><identifier>CODEN: ANNED3</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Anticonvulsants - therapeutic use ; Biological and medical sciences ; Cognition - drug effects ; Decision Making ; Demography ; Epilepsy - complications ; Epilepsy - drug therapy ; Female ; Glioma - classification ; Glioma - complications ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Male ; Medical sciences ; Memory, Short-Term ; Mental Processes ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropsychological Tests ; Psychometrics ; Psychomotor Performance ; Quality of Life ; Sickness Impact Profile ; Tumors of the nervous system. Phacomatoses ; Verbal Learning</subject><ispartof>Annals of neurology, 2003-10, Vol.54 (4), p.514-520</ispartof><rights>Copyright © 2003 American Neurological Association</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4552-794638614fb652317c1c21db9835e4a11a4634ed8f75733ad869a127512adda03</citedby><cites>FETCH-LOGICAL-c4552-794638614fb652317c1c21db9835e4a11a4634ed8f75733ad869a127512adda03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.10712$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.10712$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15179840$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14520665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klein, Martin</creatorcontrib><creatorcontrib>Engelberts, Nadine H. J.</creatorcontrib><creatorcontrib>van der Ploeg, Henk M.</creatorcontrib><creatorcontrib>Kasteleijn-Nolst Trenité, Dorotheé G. A.</creatorcontrib><creatorcontrib>Aaronson, Neil K.</creatorcontrib><creatorcontrib>Taphoorn, Martin J. B.</creatorcontrib><creatorcontrib>Baaijen, Hans</creatorcontrib><creatorcontrib>Vandertop, W. Peter</creatorcontrib><creatorcontrib>Muller, Martin</creatorcontrib><creatorcontrib>Postma, Tjeerd J.</creatorcontrib><creatorcontrib>Heimans, Jan J.</creatorcontrib><title>Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Low‐grade gliomas frequently are associated with epilepsy. The purpose of this study is to determine the impact of epilepsy and antiepileptic drug (AED) treatment on cognitive functioning and health‐related quality of life (HRQOL) in these patients. One hundred fifty‐six patients without clinical or radiological signs of tumor recurrence for at least 1 year after histological diagnosis and with an epilepsy burden (based on seizure frequency and AED use) ranging from none to severe were compared with healthy controls. The association between epilepsy burden and cognition/HRQOL was also investigated. Eighty‐six percent of the patients had epilepsy and 50% of those using AEDs actually were seizure‐free. Compared with healthy controls, glioma patients had significant reductions in information processing speed, psychomotor function, attentional functioning, verbal and working memory, executive functioning, and HRQOL. The increase in epilepsy burden that was associated with significant reductions in all cognitive domains except for attentional and memory functioning could primarily be attributed to the use of AEDs, whereas the decline in HRQOL could be ascribed to the lack of complete seizure control. In conclusion, low‐grade glioma patients suffer from a number of neuropsychological and psychological problems that are aggravated by the severity of epilepsy and by the intensity of the treatment.</description><subject>Adult</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cognition - drug effects</subject><subject>Decision Making</subject><subject>Demography</subject><subject>Epilepsy - complications</subject><subject>Epilepsy - drug therapy</subject><subject>Female</subject><subject>Glioma - classification</subject><subject>Glioma - complications</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory, Short-Term</subject><subject>Mental Processes</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Psychometrics</subject><subject>Psychomotor Performance</subject><subject>Quality of Life</subject><subject>Sickness Impact Profile</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>Verbal Learning</subject><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhi0EotvCgT-AfKESh7QefybcVqEtlar20KIerVnHWQzOR-OEsv--WXahp5488jzvzOgh5AOwE2CMn2KLc2GAvyILUAKynMviNVkwoWWmQMgDcpjST8ZYoYG9JQcgFWdaqwW5PetD9H3a0NDS2D1m6wErT9cxdA2mL_Tuh6eh6dGNtGup69ZtGMNvT-updWOYv7Ct6MOEMYwb2tU0htq_I29qjMm_379H5Pv52V35Lbu6ubgsl1eZk0rxzBRSi1yDrFdacQHGgeNQrYpcKC8RAOe-9FVeG2WEwCrXBQI3CjhWFTJxRI53c_uhe5h8Gm0TkvMxYuu7KdltDIzJZ_DzDnRDl9Lga9sPocFhY4HZrUE7G7R_Dc7sx_3QadX46pncK5uBT3sAk8NYD9i6kJ45BabI5fa60x33OAvevLzRLq-X_1Znu0RIo__zP4HDL6uNMMreX19Y-bU8L2_vS1uIJywslI4</recordid><startdate>200310</startdate><enddate>200310</enddate><creator>Klein, Martin</creator><creator>Engelberts, Nadine H. J.</creator><creator>van der Ploeg, Henk M.</creator><creator>Kasteleijn-Nolst Trenité, Dorotheé G. A.</creator><creator>Aaronson, Neil K.</creator><creator>Taphoorn, Martin J. B.</creator><creator>Baaijen, Hans</creator><creator>Vandertop, W. Peter</creator><creator>Muller, Martin</creator><creator>Postma, Tjeerd J.</creator><creator>Heimans, Jan J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Willey-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200310</creationdate><title>Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life</title><author>Klein, Martin ; Engelberts, Nadine H. J. ; van der Ploeg, Henk M. ; Kasteleijn-Nolst Trenité, Dorotheé G. A. ; Aaronson, Neil K. ; Taphoorn, Martin J. B. ; Baaijen, Hans ; Vandertop, W. Peter ; Muller, Martin ; Postma, Tjeerd J. ; Heimans, Jan J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4552-794638614fb652317c1c21db9835e4a11a4634ed8f75733ad869a127512adda03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cognition - drug effects</topic><topic>Decision Making</topic><topic>Demography</topic><topic>Epilepsy - complications</topic><topic>Epilepsy - drug therapy</topic><topic>Female</topic><topic>Glioma - classification</topic><topic>Glioma - complications</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory, Short-Term</topic><topic>Mental Processes</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Psychometrics</topic><topic>Psychomotor Performance</topic><topic>Quality of Life</topic><topic>Sickness Impact Profile</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>Verbal Learning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klein, Martin</creatorcontrib><creatorcontrib>Engelberts, Nadine H. J.</creatorcontrib><creatorcontrib>van der Ploeg, Henk M.</creatorcontrib><creatorcontrib>Kasteleijn-Nolst Trenité, Dorotheé G. A.</creatorcontrib><creatorcontrib>Aaronson, Neil K.</creatorcontrib><creatorcontrib>Taphoorn, Martin J. B.</creatorcontrib><creatorcontrib>Baaijen, Hans</creatorcontrib><creatorcontrib>Vandertop, W. Peter</creatorcontrib><creatorcontrib>Muller, Martin</creatorcontrib><creatorcontrib>Postma, Tjeerd J.</creatorcontrib><creatorcontrib>Heimans, Jan J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klein, Martin</au><au>Engelberts, Nadine H. J.</au><au>van der Ploeg, Henk M.</au><au>Kasteleijn-Nolst Trenité, Dorotheé G. A.</au><au>Aaronson, Neil K.</au><au>Taphoorn, Martin J. B.</au><au>Baaijen, Hans</au><au>Vandertop, W. Peter</au><au>Muller, Martin</au><au>Postma, Tjeerd J.</au><au>Heimans, Jan J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>2003-10</date><risdate>2003</risdate><volume>54</volume><issue>4</issue><spage>514</spage><epage>520</epage><pages>514-520</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><coden>ANNED3</coden><abstract>Low‐grade gliomas frequently are associated with epilepsy. The purpose of this study is to determine the impact of epilepsy and antiepileptic drug (AED) treatment on cognitive functioning and health‐related quality of life (HRQOL) in these patients. One hundred fifty‐six patients without clinical or radiological signs of tumor recurrence for at least 1 year after histological diagnosis and with an epilepsy burden (based on seizure frequency and AED use) ranging from none to severe were compared with healthy controls. The association between epilepsy burden and cognition/HRQOL was also investigated. Eighty‐six percent of the patients had epilepsy and 50% of those using AEDs actually were seizure‐free. Compared with healthy controls, glioma patients had significant reductions in information processing speed, psychomotor function, attentional functioning, verbal and working memory, executive functioning, and HRQOL. The increase in epilepsy burden that was associated with significant reductions in all cognitive domains except for attentional and memory functioning could primarily be attributed to the use of AEDs, whereas the decline in HRQOL could be ascribed to the lack of complete seizure control. In conclusion, low‐grade glioma patients suffer from a number of neuropsychological and psychological problems that are aggravated by the severity of epilepsy and by the intensity of the treatment.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>14520665</pmid><doi>10.1002/ana.10712</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-5134
ispartof Annals of neurology, 2003-10, Vol.54 (4), p.514-520
issn 0364-5134
1531-8249
language eng
recordid cdi_proquest_miscellaneous_75731778
source MEDLINE; Wiley Online Library
subjects Adult
Anticonvulsants - therapeutic use
Biological and medical sciences
Cognition - drug effects
Decision Making
Demography
Epilepsy - complications
Epilepsy - drug therapy
Female
Glioma - classification
Glioma - complications
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Male
Medical sciences
Memory, Short-Term
Mental Processes
Middle Aged
Nervous system (semeiology, syndromes)
Neurology
Neuropsychological Tests
Psychometrics
Psychomotor Performance
Quality of Life
Sickness Impact Profile
Tumors of the nervous system. Phacomatoses
Verbal Learning
title Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A26%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epilepsy%20in%20low-grade%20gliomas:%20The%20impact%20on%20cognitive%20function%20and%20quality%20of%20life&rft.jtitle=Annals%20of%20neurology&rft.au=Klein,%20Martin&rft.date=2003-10&rft.volume=54&rft.issue=4&rft.spage=514&rft.epage=520&rft.pages=514-520&rft.issn=0364-5134&rft.eissn=1531-8249&rft.coden=ANNED3&rft_id=info:doi/10.1002/ana.10712&rft_dat=%3Cproquest_cross%3E75731778%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75731778&rft_id=info:pmid/14520665&rfr_iscdi=true